Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-082981
Filing Date
2011-03-30
Accepted
2011-03-30 16:39:19
Documents
17
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1476337
2 SECOND AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY dex1032.htm EX-10.32 15717
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 6704
4 CERTIFICATION OF THE COMPANY'S CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9606
5 CERTIFICATION OF THE COMPANY'S CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9735
6 CERTIFICATION OF THE COMPANY'S CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3671
7 GRAPHIC g168773g15i55.jpg GRAPHIC 84872
8 GRAPHIC g168773g22k63.jpg GRAPHIC 24497
9 GRAPHIC g168773g25s27.jpg GRAPHIC 79518
10 GRAPHIC g168773g42x06.jpg GRAPHIC 57518
11 GRAPHIC g168773g57l84.jpg GRAPHIC 21470
12 GRAPHIC g168773g61o87.jpg GRAPHIC 23297
13 GRAPHIC g168773g63g61.jpg GRAPHIC 82444
14 GRAPHIC g168773g71g52.jpg GRAPHIC 29468
15 GRAPHIC g168773g85a21.jpg GRAPHIC 40775
16 GRAPHIC g168773g88i65.jpg GRAPHIC 22332
17 GRAPHIC g168773g93f89.jpg GRAPHIC 26920
  Complete submission text file 0001193125-11-082981.txt   2203952
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51967 | Film No.: 11722570
SIC: 2834 Pharmaceutical Preparations